MIDAS Financing PLC. (DSE:MIDASFIN)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions BDT. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-379.54	-321.95	-671.24	8.6	84.43	115.29
Depreciation & Amortization	21.08	18.82	24.2	19.62	19.81	20.81
Other Amortization	3.24	7.11	-	-	-	-
Provision for Credit Losses	-2.51	-2.51	682.75	76.46	305.64	-69.69
Change in Trading Asset Securities	179.34	179.34	-2.13	-1.66	42.61	-15.16
Change in Income Taxes	-18.59	-18.59	-21.3	-28.59	-34.9	-30.59
Change in Other Net Operating Assets	731.38	522.27	214.55	-586.5	-5.91	-109.07
Other Operating Activities	-62.75	-77.2	245.57	-45.37	-223.35	20.85
Operating Cash Flow	471.66	307.3	472.41	-553.28	188.34	-67.51
Operating Cash Flow Growth	-23.43%	-34.95%	-	-	-	-
Capital Expenditures	-1.32	-2.67	-3.69	-16.96	-1.96	-0.85
Sale of Property, Plant & Equipment	0.11	0.11	0.11	17.16	0.04	0.01
Investing Cash Flow	1.93	-2.56	-3.58	0.2	-1.92	-0.84
Long-Term Debt Issued	-	47.97	-	606.97	26.58	135.07
Total Debt Issued	28.3	47.97	-	606.97	26.58	135.07
Long-Term Debt Repaid	-	-	-275.45	-	-	-
Net Debt Issued (Repaid)	-52.49	47.97	-275.45	606.97	26.58	135.07
Common Dividends Paid	-	-	-21.58	-14.25	-34.75	-33.9
Financing Cash Flow	-52.49	47.97	-297.04	592.72	-8.17	101.17
Net Cash Flow	421.1	352.7	171.79	39.65	178.26	32.83
Free Cash Flow	470.34	304.63	468.72	-570.24	186.39	-68.36
Free Cash Flow Growth	-23.16%	-35.01%	-	-	-	-
Free Cash Flow Margin	-	-	-	-222.49%	81.23%	-32.10%
Free Cash Flow Per Share	3.27	2.12	3.26	-3.96	1.29	-0.47
Cash Interest Paid	685.69	723.65	733.25	706.41	970.7	856.36
Cash Income Tax Paid	14.46	18.59	21.3	28.59	34.9	30.59

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.